Zynex Inc Total Assets

Latest as of September 2025: $45.32 Million USD

Zynex Inc total assets. Based on the latest financial reports, Zynex Inc (ZYXI) holds total assets worth $45.32 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Zynex Inc worth for the company's overall valuation and market capitalisation.

Total Assets of Zynex Inc (1998–2024)

Total assets of Zynex Inc from 1998 to 2024. This chart illustrates how Zynex Inc's total assets have evolved over time, based on quarterly financial data. See Zynex Inc (ZYXI) stock price for real-time trading data and today's change.

Zynex Inc - Asset Composition Analysis

Zynex Inc Total Assets Breakdown (December 2024)

Zynex Inc total assets breakdown as of December 2024. Zynex Inc's total assets of $45.32 Million consist of 61.6% current assets and 38.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 32.5%
Accounts Receivable $18.02 Million 14.8%
Inventory $13.92 Million 11.4%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $7.25 Million 5.9%
Goodwill $20.40 Million 16.7%

Asset Composition Trend (1998–2024)

This chart illustrates how Zynex Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ZYXI working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Zynex Inc's current assets represent 61.6% of total assets in 2024, a decrease from 100.0% in 1998.
  • Cash Position: Cash and equivalents constituted 32.5% of total assets in 2024, up from 0.0% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1998.
  • Asset Diversification: The largest asset category is goodwill at 16.7% of total assets.

Zynex Inc Competitors by Total Assets

Key competitors of Zynex Inc based on total assets are shown below.

Company Country Total Assets
Hanmi Science
KO:008930
Korea ₩1.49 Trillion
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
China CN¥21.18 Billion
ShareHope Medicine Co Ltd
TWO:8403
Taiwan NT$6.62 Billion
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion

Zynex Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.47 3.94 6.23
Quick Ratio 0.32 3.15 5.38
Cash Ratio 0.00 0.00 0.00
Working Capital $-41.83 Million $58.48 Million $52.91 Million

Zynex Inc - Advanced Valuation Insights

This section examines the relationship between Zynex Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 34.84
Latest Market Cap to Assets Ratio 0.02
Asset Growth Rate (YoY) -10.8%
Total Assets $122.08 Million
Market Capitalization $2.61 Million USD

Valuation Analysis

Below Book Valuation: The market values Zynex Inc's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Zynex Inc's assets decreased by 10.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Zynex Inc (1998–2024)

The table below shows the annual total assets of Zynex Inc from 1998 to 2024.

Year Total Assets Change
2024-12-31 $122.08 Million -10.83%
2023-12-31 $136.90 Million +13.75%
2022-12-31 $120.35 Million -9.70%
2021-12-31 $133.27 Million +79.56%
2020-12-31 $74.22 Million +162.49%
2019-12-31 $28.28 Million +74.72%
2018-12-31 $16.18 Million +81.25%
2017-12-31 $8.93 Million +118.26%
2016-12-31 $4.09 Million +10.69%
2015-12-31 $3.70 Million -48.05%
2014-12-31 $7.11 Million -58.69%
2013-12-31 $17.22 Million -33.53%
2012-12-31 $25.91 Million +18.93%
2011-12-31 $21.79 Million +38.75%
2010-12-31 $15.70 Million +31.61%
2009-12-31 $11.93 Million +10.63%
2008-12-31 $10.78 Million +50.30%
2007-12-31 $7.18 Million +159.19%
2006-12-31 $2.77 Million +105.84%
2005-12-31 $1.34 Million +70.33%
2004-12-31 $789.60K +83.63%
2003-12-31 $430.00K +193.99%
2000-12-31 $146.26K +119788.52%
1999-12-31 $122.00 0.00%
1998-12-31 $122.00 --

About Zynex Inc

NASDAQ:ZYXI USA Medical Distribution
Market Cap
$2.61 Million
Market Cap Rank
#29684 Global
#6063 in USA
Share Price
$0.09
Change (1 day)
+7.50%
52-Week Range
$0.03 - $1.59
All Time High
$25.72
About

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more